As shown in Supplementary Figure 1C, increased expression of GADD45A, PUMA, p21 and PAI-1 correlates with better prognosis in patients with ERα-positive breast cancer after endocrine therapy and chemotherapy. The gene discussed is CDKN1A; the disease is breast cancer.